What a difference a day can make in the biotech world. On Friday, shares of Ocugen (NASDAQ: OCGN) fell by 5.8%, quite a contrast from the 10%-plus gain of the preceding day. Investors might have been looking at the big picture of the coronavirus vaccine the company is linked to, and not enjoying the view.